Will the Momentum Continue? Gracell Biotechnologies Inc (NASDAQ:GRCL)

Gracell Biotechnologies Inc (NASDAQ:GRCL) stock gained momentum on Friday.

Market Action

GRCL stock surged 20.70% to end the session at $17.61. More than 1.23 million shares traded hands – 12 X its 30-day average of 100K shares. The stock opened at $15.85 and moved within a wide range of $ 15.68 – 19.74.

GRCL Released News This Week

May 20, 2021 – Gracell Biotechnologies to Present Updated Results of GC012F FasTCAR-enabled BCMA/CD19 Dual-targeting CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma at ASCO 2021 and EHA 2021

  • presenting updated results of their first-in-human multicenter study of GC012F for the treatment of relapsed and/or refractory multiple myeloma, a FasTCAR-enabled BCMA/CD19 dual-targeting CAR-T cell therapy currently in development for the treatment of multiple myeloma, at the 2021 American Society of Clinical Oncology (“ASCO”) Annual Meeting and the European Hematology Association 2021 (“EHA2021”) Congress.
  • GC012F is a BCMA/CD19 dual-targeting CAR-T cell therapy developed on Gracell’s proprietary FasTCAR next-day manufacturing technology platform and is being evaluated in a Phase 1 investigator-initiated trial study.

Trader Notes

Share Information

SHARES OUTSTANDING19.81 M
SHARE FLOAT (%)19.35 M –
% HELD BY INSTITUTIONS97.88

Recent Stock Performance

5-DAY PERF.+59.37%
1-MONTH PERF.+38.77%
3-MONTH PERF.-32.68%
6-MONTH PERF.
YTD PERF.
1-YEAR PERF.

Moving Averages

+/- EMA(20)12.91 (+36.41%)
+/- SMA(50)14.91 (+18.11%)
+/- SMA(200)19.36 (-9.04%)

Pivot Points

NameS3S2S1Pivot PointsR1R2R3
Classic3.93333.93673.94333.94673.95333.95673.9633
Fibonacci3.93673.94053.94283.94673.95053.95283.9567

Technical Indicators

SymbolValueResultSymbolValueResult
ADX15.6378NeutralATR140.1342
CCI20-87.7412SellMACD0.0413Buy
Money Flow Index23.9754SellROC-4.9338Sell
RSI46.3348SellSTOCH (14,3)8.3333OverSold
STOCH RSI0.0427OverSoldUO43.2695Sell

Related Posts

About The Author